Venkata Renduchintala Net Worth

The estimated Net Worth of Venkata S M Renduchintala is at least $17.6 Million dollars as of 29 September 2020. Venkata Renduchintala owns over 1,283 units of Accenture plc stock worth over $1,176,341 and over the last 12 years he sold ACN stock worth over $16,090,013. In addition, he makes $324,942 as Independent Director at Accenture plc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Venkata Renduchintala ACN stock SEC Form 4 insiders trading

Venkata has made over 66 trades of the Accenture plc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 1,283 units of ACN stock worth $286,122 on 29 September 2020.

The largest trade he's ever made was exercising 92,314 units of Accenture plc stock on 2 March 2020 worth over $32,338,517. On average, Venkata trades about 8,668 units every 23 days since 2012. As of 29 September 2020 he still owns at least 3,358 units of Accenture plc stock.

You can see the complete history of Venkata Renduchintala stock trades at the bottom of the page.

Venkata Renduchintala biography

Dr. Venkata S. M. Renduchintala Ph.D. serves as Independent Director of the Company. He has been chief engineering officer at Intel Corporation, a computer products and technology company, since November 2015. He also serves as group president of the Technology, Manufacturing and Systems Architecture Group. Before assuming his current position, Dr. Renduchintala held various senior positions at Qualcomm Incorporated, a mobile technology company, most recently as executive vice president, Qualcomm Technologies and co-president of Qualcomm CDMA Technologies from 2012 to 2015, where he led the semiconductor business in the computer and mobile segments. Dr. Renduchintala joined Qualcomm Technologies in 2004 from Skyworks Solutions, Inc., where he was vice president and general manager of the Cellular Systems division from 2000 to 2004. Prior to Skyworks, he spent a decade with Philips Electronics, Inc. progressing to become vice president of engineering for its consumer communications business.

What is the salary of Venkata Renduchintala?

As the Independent Director of Accenture plc, the total compensation of Venkata Renduchintala at Accenture plc is $324,942. There are 16 executives at Accenture plc getting paid more, with David Rowland having the highest compensation of $15,031,900.

How old is Venkata Renduchintala?

Venkata Renduchintala is 54, he's been the Independent Director of Accenture plc since 2018. There are 22 older and 6 younger executives at Accenture plc. The oldest executive at Accenture plc is Herbert Hainer, 65, who is the Independent Director.

What's Venkata Renduchintala's mailing address?

Venkata's mailing address filed with the SEC is C/O ACCENTURE, 500 W. MADISON STREET, CHICAGO, IL, 60661.

Insiders trading at Accenture plc

Over the last 14 years, insiders at Accenture plc have traded over $571,571,901 worth of Accenture plc stock and bought 20,000 units worth $1,439,800 . The most active insiders traders include Beth E Mooney, Venkata S M Renduchintala, and Pierre Nanterme. On average, Accenture plc executives and independent directors trade stock every 8 days with the average trade being worth of $2,487,902. The most recent stock trade was executed by Ellyn Shook on 23 July 2024, trading 5,000 units of ACN stock currently worth $1,649,100.

What does Accenture plc do?

Accenture plc is an Irish-American professional services company based in Dublin, specializing in information technology services and consulting. A Fortune Global 500 company, it reported revenues of $61.6 billion in 2022.

Complete history of Venkata Renduchintala stock trades at First Solar Inc, Intel, Qualcomm, and Accenture plc

Accenture plc executives and stock owners

Accenture plc executives and other stock owners filed with the SEC include:

• David Rowland,
  Executive Chairman of the Board
• Julie T. Spellman Sweet,
  CEO & Chairman
• Julie Sweet,
  Chief Executive Officer, Director
• Gianfranco Casati,
  Group Chief Executive - Growth Markets
• Gianfranco Casati,
  Chief Exec. Officer of Growth Markets
• KC McClure,
  Chief Financial Officer
• Jean-Marc Ollagnier,
  Chief Exec. Officer of Europe
• Kathleen R. McClure,
  Chief Financial Officer
• David P. Rowland,
  Exec. Chairman & Advisor to CEO
• Paula Price,
  Independent Director
• Jaime Ardila,
  Independent Director
• Nancy McKinstry,
  Independent Director
• Tracey Travis,
  Independent Director
• Gilles Christian Pelisson,
  Lead Independent Director
• Arun Sarin,
  Independent Director
• Herbert Hainer,
  Independent Director
• Venkata Renduchintala,
  Independent Director
• Frank Tang,
  Independent Director
• Joel Unruch,
  Chief Compliance Officer, General Counsel, Secretary
• James Etheredge,
  Chief Executive, North America
• Domingo Miron,
  Group Chief Executive - Financial Services
• Simon Eaves,
  Group Chief Executive - Products Operating Group
• John Walsh,
  Group Chief Executive Officer - Communications, Media and Technology
• Richard Clark,
  Chief Accounting Officer, Corporate Controller
• Ellyn Shook,
  Chief Human Resource Officer, Chief Leadership Officer
• Johan Deblaere,
  Chief Operating Officer, Chief Executive - Europe
• Jean-Marc Ollagnier,
  Group Chief Executive - Resources Operating Group
• Daniel London,
  Group Chief Executive - Health & Public Service Operating Group
• Jill Kramer,
  Chief Marketing & Communications Officer
• Joel Unruch,
  Gen. Counsel & Corp. Sec.
• Joel F. Unruch,
  Gen. Counsel & Corp. Sec.
• Angie Park,
  Managing Director & Head of Investor Relations
• Paul R. Daugherty,
  Group Chief Exec. of Technology & CTO
• Richard P. Clark,
  Chief Accounting Officer & Chief Transformation Officer – Bus. Enablement
• Johan G. Deblaere,
  Chief Operating Officer
• Omar Abbosh,
  Grp Chief Exec-Com, Med & Tech
• Charles H Giancarlo,
  Director
• Dina Dublon,
  Director
• William L Kimsey,
  Director
• Robert E Sell,
  Grp Chief Exec-Com, Med & Tech
• Marjorie Magner,
  Director
• Chad T Jerdee,
  General Counsel and CCO
• Wulf Von Schimmelmann,
  Director
• Blythe J Mcgarvie,
  Director
• Beth E Mooney,
  Director
• Leonardo Framil,
  CEO-Growth Markets
• Melissa A Burgum,
  Chief Accounting Officer
• Kathleen R Mc Clure,
  Chief Financial Officer
• Stephen J Rohleder,
  Group Chief Exec-Health & PS
• Mark Moodystuart,
  Director
• Nobuyuki Idei,
  Director
• Michael J Salvino,
  Group Chief Exec-Bus Proc Out
• Shawn Collinson,
  Sr Managing Dir-Growth & Strat
• Martin I Cole,
  Grp Chief Exec-Comm & HighTech
• 'T Noordende Alexander M Van,
  Group Chief Exec-Products
• Pierre Nanterme,
  Chief Executive Officer
• Jill Smart,
  Chief Human Resources Officer
• Richard Lumb,
  Group Chief Executive-Fin Serv
• Robert I Lipp,
  Director
• William D Green,
  Chairman
• Anthony G Coughlan,
  Principal Accounting Officer
• Pamela J. Craig,
  Chief Financial Officer
• Dennis F Hightower,
  Director
• Jeffrey D Osborne,
  Chief Performance Officer
• Kevin M Campbell,
  Group Chief Exec-Technology
• Robert N Frerichs,
  Group Chief Exec-North America
• Martin Brudermueller,
  Director
• Alan C. Jope,
  Director
• Angela Beatty,
  Chief Leadership & HR Officer
• Manish Sharma,
  CEO-Americas